Healthcare / Health Information ServicesNasdaqGS
$4.99
-0.06 (-1.19%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $-52.7M · quality 55.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
27/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$358M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-167.6%
↓Gross Margin
67.4%
↑Debt/Equity
1.34
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+17.6%
FCF CAGR
—
FCF margin
-57.6%
FCF / Net income
0.56x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $77.3M · net income $-79.0M · FCF $-44.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $77.3M | $77.3M | $65.2M | $62.4M | $47.6M |
| Net Income | $-79.0M | $-79.0M | $-62.5M | $-79.0M | $-87.4M |
| EBITDA | $-63.4M | $-63.4M | $-50.8M | $-69.6M | $-81.4M |
| EPS | -1.17 | -1.17 | -0.95 | -1.22 | -1.36 |
| Gross Margin | 67.4% | 67.4% | 67.4% | 68.8% | 65.7% |
| Operating Margin | -91.8% | -91.8% | -102.1% | -120.0% | -184.7% |
| Net Margin | -102.2% | -102.2% | -95.9% | -126.6% | -183.9% |
| Balance Sheet | |||||
| Debt/Equity | 1.34 | 1.34 | 0.31 | 0.12 | 0.08 |
| Current Ratio | 2.06 | 2.06 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-44.5M | $-44.5M | $-52.7M | $-62.5M | $-80.5M |
| Returns | |||||
| ROE | -167.6% | -167.6% | -64.8% | -52.2% | -43.7% |
| Valuation | |||||
| P/B | 7.15 | 7.15 | 2.22 | 2.20 | 0.63 |
| Growth & Yield | |||||
| Revenue Growth | 18.6% | 18.6% | 4.5% | 31.1% | — |
| EPS Growth | -23.2% | -23.2% | 22.1% | 10.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+66.3%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.95 → -1.17
Residual
+66.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.